Search Results - "BABA, Yoshifumi"

Refine Results
  1. 1

    Tumor immune microenvironment and immune checkpoint inhibitors in esophageal squamous cell carcinoma by Baba, Yoshifumi, Nomoto, Daichi, Okadome, Kazuo, Ishimoto, Takatsugu, Iwatsuki, Masaaki, Miyamoto, Yuji, Yoshida, Naoya, Baba, Hideo

    Published in Cancer science (01-09-2020)
    “…Esophageal squamous cell carcinoma (ESCC) is the main prevalent histological type of esophageal cancer, predominantly constituting 90% of cases worldwide…”
    Get full text
    Journal Article
  2. 2

    Aspirin Use, Tumor PIK3CA Mutation, and Colorectal-Cancer Survival by Liao, Xiaoyun, Lochhead, Paul, Nishihara, Reiko, Morikawa, Teppei, Kuchiba, Aya, Yamauchi, Mai, Imamura, Yu, Qian, Zhi Rong, Baba, Yoshifumi, Shima, Kaori, Sun, Ruifang, Nosho, Katsuhiko, Meyerhardt, Jeffrey A, Giovannucci, Edward, Fuchs, Charles S, Chan, Andrew T, Ogino, Shuji

    Published in The New England journal of medicine (25-10-2012)
    “…In this study, mortality from colorectal cancer was reduced by about 80% in a subgroup of patients with tumors that expressed a mutated, activated form of…”
    Get full text
    Journal Article
  3. 3

    The microbiome, genetics, and gastrointestinal neoplasms: the evolving field of molecular pathological epidemiology to analyze the tumor–immune–microbiome interaction by Mima, Kosuke, Kosumi, Keisuke, Baba, Yoshifumi, Hamada, Tsuyoshi, Baba, Hideo, Ogino, Shuji

    Published in Human genetics (01-05-2021)
    “…Metagenomic studies using next-generation sequencing technologies have revealed rich human intestinal microbiome, which likely influence host immunity and…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Intratumoral Fusobacterium Nucleatum Levels Predict Therapeutic Response to Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma by Yamamura, Kensuke, Izumi, Daisuke, Kandimalla, Raju, Sonohara, Fuminori, Baba, Yoshifumi, Yoshida, Naoya, Kodera, Yasuhiro, Baba, Hideo, Goel, Ajay

    Published in Clinical cancer research (15-10-2019)
    “…Emerging evidence indicates that gut microbiome plays a crucial role in the cancer pathogenesis. Although ( ) is associated with poor prognosis in multiple…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Sarcopenia is a Negative Prognostic Factor After Curative Resection of Colorectal Cancer by Miyamoto, Yuji, Baba, Yoshifumi, Sakamoto, Yasuo, Ohuchi, Mayuko, Tokunaga, Ryuma, Kurashige, Junji, Hiyoshi, Yukiharu, Iwagami, Shiro, Yoshida, Naoya, Yoshida, Megumi, Watanabe, Masayuki, Baba, Hideo

    Published in Annals of surgical oncology (01-08-2015)
    “…Background Skeletal muscle depletion (sarcopenia) is closely associated with limited physical ability and high mortality. This study was performed to evaluate…”
    Get full text
    Journal Article
  8. 8

    Glucose transporter 1 regulates the proliferation and cisplatin sensitivity of esophageal cancer by Sawayama, Hiroshi, Ogata, Yoko, Ishimoto, Takatsugu, Mima, Kosuke, Hiyoshi, Yukiharu, Iwatsuki, Masaaki, Baba, Yoshifumi, Miyamoto, Yuji, Yoshida, Naoya, Baba, Hideo

    Published in Cancer science (01-05-2019)
    “…Glucose transporter 1 (GLUT1) expression is a prognostic marker for esophageal squamous cell carcinoma (ESCC). Recent work on GLUT1 and development of specific…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Progress in characterizing the linkage between Fusobacterium nucleatum and gastrointestinal cancer by Liu, Yang, Baba, Yoshifumi, Ishimoto, Takatsugu, Iwatsuki, Masaaki, Hiyoshi, Yukiharu, Miyamoto, Yuji, Yoshida, Naoya, Wu, Rong, Baba, Hideo

    Published in Journal of gastroenterology (01-01-2019)
    “…Microbiome research is a rapidly advancing field in human cancers. Fusobacterium nucleatum is an oral bacterium, indigenous to the human oral cavity, that…”
    Get full text
    Journal Article
  14. 14
  15. 15

    The role of microRNA in esophageal squamous cell carcinoma by Harada, Kazuto, Baba, Yoshifumi, Ishimoto, Takatsugu, Shigaki, Hironobu, Kosumi, Keisuke, Yoshida, Naoya, Watanabe, Masayuki, Baba, Hideo

    Published in Journal of Gastroenterology (01-06-2016)
    “…MicroRNAs (miRNA) are 22-nucleotide non-coding RNAs that post-transcriptionally regulate gene expression by base pairing to partially complementary sequences…”
    Get full text
    Journal Article Book Review
  16. 16

    Gut microbiome in gastrointestinal cancer: a friend or foe? by Liu, Yang, Baba, Yoshifumi, Ishimoto, Takatsugu, Gu, Xi, Zhang, Jun, Nomoto, Daichi, Okadome, Kazuo, Baba, Hideo, Qiu, Peng

    “…The impact of the gut microbiome on host health is becoming increasingly recognized. To date, there is growing evidence that the complex characteristics of the…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Clinicopathological characteristics and prognosis of poorly cohesive cell subtype of gastric cancer by Nakamura, Kenichi, Eto, Kojiro, Iwagami, Shiro, Ogawa, Katsuhiro, Sawayama, Hiroshi, Ishimoto, Takatsugu, Iwatsuki, Masaaki, Baba, Yoshifumi, Miyamoto, Yuji, Yoshida, Naoya, Baba, Hideo

    Published in International journal of clinical oncology (01-03-2022)
    “…Background The new World Health Organization (WHO) classification of gastric cancer includes a histological subtype of poorly cohesive carcinoma (PCC), which…”
    Get full text
    Journal Article
  19. 19

    The microbiome and hepatobiliary-pancreatic cancers by Mima, Kosuke, Nakagawa, Shigeki, Sawayama, Hiroshi, Ishimoto, Takatsugu, Imai, Katsunori, Iwatsuki, Masaaki, Hashimoto, Daisuke, Baba, Yoshifumi, Yamashita, Yo-ichi, Yoshida, Naoya, Chikamoto, Akira, Baba, Hideo

    Published in Cancer letters (28-08-2017)
    “…Abstract The human intestinal microbiome encompasses at least 100 trillion microorganisms that can influence host immunity and disease conditions, including…”
    Get full text
    Journal Article
  20. 20

    Minimally invasive esophagectomy for esophageal cancer: an updated review by Watanabe, Masayuki, Baba, Yoshifumi, Nagai, Yohei, Baba, Hideo

    Published in Surgery today (Tokyo, Japan) (01-03-2013)
    “…Purpose The surgical, postoperative and oncologic outcomes of minimally invasive esophagectomy (MIE) for esophageal cancer were reviewed to clarify the…”
    Get full text
    Journal Article